32.58
前日終値:
$32.51
開ける:
$32.4583
24時間の取引高:
2,557
Relative Volume:
0.42
時価総額:
$N/A
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+0.64%
1か月 パフォーマンス:
+5.27%
6か月 パフォーマンス:
+11.56%
1年 パフォーマンス:
-0.16%
Tema Heart Health Etf Stock (HRTS) Company Profile
HRTS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
HRTS
Tema Heart Health Etf
|
32.58 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
335.42 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
682.06 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
685.23 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
254.99 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
629.07 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Heart Health Etf (HRTS) 最新ニュース
The Investor's Guide to Buying GLP-1 Stocks - The Motley Fool
How Tema ETF Trust Tema American stock trades after rate cuts2025 Key Highlights & Consistent Income Trade Ideas - Trung tâm Dự báo KTTV quốc gia
5 Small-cap Biotech ETFs to Watch in 2025 - Investing News Network
Tema Launches First International Defense Innovation ETF (GDFN) - Yahoo Finance
Tema Launches International Durable Quality ETF (ITOL) - Yahoo Finance
Medtronic Plummets 4.2% on Earnings Optimism Overshadowed by Activist Investor Moves - AInvest
The stock price of Novo-Nordisk A/S plummeted by nearly 22%; what happened? - 富途牛牛
Short Interest in Tema Heart & Health ETF (NASDAQ:HRTS) Decreases By 62.5% - Defense World
OFS Credit Company, Inc. (NASDAQ:OCCIN) Sees Significant Decline in Short Interest - Defense World
Northern Graphite (CVE:NGC) Shares Up 42.1% – Time to Buy? - Defense World
Tema Announces Liquidation of Two ETFs - Yahoo Finance
5 Small-cap Biotech ETFs to Watch - Nasdaq
AMGEN AND FOOTBALL LEGEND BARRY SANDERS HIGHLIGHT DANGERS OF BAD CHOLESTEROL IN NEW DOCUMENTARY - Investing News Network
Weight-Loss Drug ETFs Generate Skinnier Returns Than Expected - The Daily Upside
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177 - Investing News Network
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs - ETF Trends
Why the Rich World Is Going to Need AI and Africa - Bloomberg.com
Disruptive Theme of the Week: 2024's Top Investment Themes & Trends - ETF Trends
Tema's New VOLT ETF Sparked by AI Revolution - Yahoo Finance
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Nasdaq
Tap the Weight-Loss Drug Market With These ETFs - Nasdaq
Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says - CNBC
Disruptive Theme of the Week: The Rise of Active Thematic ETFs - ETF Trends
HRTS: Exposure To GLP-1 Drug Developers Means Plenty Of Upside - Seeking Alpha
ETF Innovators: 11 people disrupting the industry, creating unique products, and delivering mammoth returns - Business Insider
This ETF is trying to satisfy appetites for weight loss stocks - CNBC
ETF IQ: Mutual Fund Managers Have the Luxury to Just Say ‘No’ - Bloomberg
Tema Neuroscience And Mental Health ETF (MNTL) Aktienkurs, Nachrichten, Kurs und Verlauf - Yahoo Finanzen
Investing in the diabesity epidemic: a breakthrough moment - CMC Markets
Obesity Market to Reach $150B as Demand Grows, Supply Stabilizes: Reuters - BioSpace
Weight-loss drug forecasts jump to $150 billion as supply grows - Reuters
Play These New ETFs to Tap Lucrative Weight Loss Drug Market - Yahoo Finance
Roundhill Glp-1 & Weight Loss ETF (OZEM) stock price, news, quote and history - Yahoo
Fighting Obesity Using ETFs - ETF Trends
S&P 500: April Selloff Could Be a Very Good Thing for the Months Ahead - Investing.com India
What Is a Healthcare ETF? Everything You Need to Know - ETF.com
The 5 Best Biotech ETFs of 2024 - ETF.com
This weight-loss ETF has performed well. Here’s a look at other options. - MarketWatch
Is the global battle against obesity an opportunity for investors? - InvestmentNews
First Weight Loss ETF from Tema ETFs Announces Name Change, Tops $50 Million AUM - FinancialContent
Feisty Rivals Take On Eli Lilly, Novo Nordisk On Weight Loss - Investor's Business Daily
Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering - Value The Markets
Tema Launches Third Medical-Themed ETF - FA Mag
The Truth HRTS - TheStreet
LLY Stock: Study Highlights Weight Regain Risk with Lilly's Zepbound - Value The Markets
HRTS Stock Fund Price and Chart — NASDAQ:HRTS - TradingView
Tema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund - Reuters
A new ETF will allow investors to cash in on the Ozempic-fueled weight loss craze that's swept markets this year - markets.businessinsider.com
Inside Tema ETFs' New Oncology ETF (CANC) - Yahoo Finance
Tema Heart Health Etf (HRTS) 財務データ
Tema Heart Health Etf (HRTS) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):